110 related articles for article (PubMed ID: 3292105)
1. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin.
Goldberg MR; Sushak CS; Rockhold FW; Thompson WL
Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparator trials with pinacidil, a potassium channel opener.
Callaghan JT; Goldberg MR; Brunelle R
Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
[TBL] [Abstract][Full Text] [Related]
3. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
Sterndorff B; Johansen P
Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
[TBL] [Abstract][Full Text] [Related]
4. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
5. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
[TBL] [Abstract][Full Text] [Related]
6. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories.
Rockhold FW; Goldberg MR; Thompson WL
J Lab Clin Med; 1989 Dec; 114(6):646-54. PubMed ID: 2687423
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
Sterndorff B; Johansen P
Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
[No Abstract] [Full Text] [Related]
11. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
Goldberg MR
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
Solomon RJ; Weinberg MS
J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
[TBL] [Abstract][Full Text] [Related]
13. Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension.
Koliopoulos K; Papadoyannis DE; Karatzas NB
Eur J Clin Pharmacol; 1984; 27(3):287-9. PubMed ID: 6510455
[TBL] [Abstract][Full Text] [Related]
14. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
Jackson B; Morgan TO; Gibson J; Anderson A
Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
[TBL] [Abstract][Full Text] [Related]
15. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
16. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
[TBL] [Abstract][Full Text] [Related]
17. Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin.
Inouye I; Massie B; Benowitz N; Simpson P; Loge D; Topic N
Am J Cardiol; 1984 Jan; 53(3):24A-28A. PubMed ID: 6320622
[TBL] [Abstract][Full Text] [Related]
18. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
19. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.
D'Arcy V; Laher M; McCoy D; Sullivan P; Walsh CH; Hickey MP
Eur J Clin Pharmacol; 1985; 28(3):347-9. PubMed ID: 4007040
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
